Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-010473

CHIEF FINANCIAL OFFICER sold 118,477 shares at an average $39.58 ($4,689,722)

  • CHIEF FINANCIAL OFFICER acquired 99,828 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Grant Sean · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

20 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-03 Exercise or conversion : show line 1 in the form +99,828 $14.87 $1,484,442 166,165 D
2024-04-03 Sale : show line 2 in the form −69,831 $40.05 $2,796,801 96,334 D
2024-04-03 Sale : show line 3 in the form −10,988 $38.65 $424,708 85,346 D
2024-04-03 Sale : show line 4 in the form −11,648 $38.13 $444,080 73,698 D
2024-04-03 Sale : show line 5 in the form −7,361 $39.25 $288,927 66,337 D
2024-04-03 Sale : show line 6 in the form −78 $38.20 $2,979 257 I
2024-04-03 Sale : show line 7 in the form −80 $39.22 $3,137 177 I
2024-04-03 Sale : show line 8 in the form −177 $40.06 $7,090 0 I
Open-market sales · 118,477 sh · avg $39.58 · $4,689,722

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-03 Exercise or conversion : show line 21 in the form Stock Option (right to buy) −99,828 80,172 D
Loading xslF345X05/form4-04062024_010405.xml…